QUV
{"type":"img","src":"https://cdn.quv.kr/dftb6ocpa%2Fup%2F624aa86e45773_1920.png","height":71,"scroll":"//cdn.quv.kr/dftb6ocpa/up/622fe9175c7c9_1920.png"}
  • COMPANY
  • TECHNOLOGY
  • PRODUCT
  • NEWS
  • CONTACT
    • {"google":["Poppins","Lato"],"custom":["Noto Sans KR","Nanum Barun Gothic","SCDream"]}
    LOGO
    ×
    섹션 설정
    {"type":"img","src":"https://cdn.quv.kr/dftb6ocpa%2Fup%2F623c218aa66fe_1920.png","height":50}
  • COMPANY
  • TECHNOLOGY
  • PRODUCT
  • NEWS
  • CONTACT

    • COMPANY

    We See the Unseen

    OUR VISION & MISSION

    Megnosis is a medical device manufacturing company

    established with the goal of

    'leading the medical field with differentiated insight'.

    Megnosis is a compound word of Medical and Gnosis.

    We aim to achieve innovation in diagnosis, treatment, and healthcare with our unique principles and

    differentiated technology that others have not seen through insight on the brain and  human.

     

    Megnosis  developed

    the world's first reactive EEG (rEEG) technology

    which can provide more information about the brain than an EEG.

     

    Based on this unique innovative technology, Megnosis intends to apply it to brain diseases

    such as Dementia, Depression,  Stroke,  Cognition, and ADHD.

     

    Megnosis also developed

    the 2-in-1 device that integrates Diagnosis & Treatment.

    The device is a biomarker  for Alzheimer's disease and can help slow or prevent the disease,

    as well as screen for and alleviate Mood Disorder  & Depression with Transcranial Electrical Stimulation.

    Analysis and reinforcement of  cognitive functions such as Memory, Emotion, Attention, Arousal, and Self-Regulation.

    Depression screening and symptom relief techniques

    Control of Sleeping Quality

    Dementia Stage Classification

    Diagnosis of all types of Dementia

    (Alzheimer's, Vascular, Frontotemporal, & Lewy Body )

    Early detection & Warning of Stroke

    Total Wearable Biosignal Healthcare System

    (Blood Pressure, SPO2, ECG, and Brainwave )

    Development of 2-in-1 Device

    (EEG + tCS)

    Real-Time Drug Monitoring

    TMS + tCS + EEG

    ADD/ADHD Diagnosis and Treatment

    Company Information

    COMPANY

    Megnosis Co., Ltd.

    Company Registration Number

    461-88-01594

    CEO

    Soonhyouk  Lee

    Establishment

    January 2020

    Type of business

    Manufacturing Medical Device

    Address

    #S102, 11-3 Techno 1-ro, Yuseong-gu, Daejeon, Korea 34015

    OUR TEAM


    OUR TEAM




    OUR HISTORY

    2020

    2020.01  Megnosis Co., Ltd. established

    2020.05  Attracted investment from

                        Actner Lab Co., Ltd.

    2020.06  TIPS 

    2020.12  Registered as a Research Institute

    2021

    2021.09  Medical device manufacturing 

                         license

    2021.09  Grade 2  GMP certified

    2020.12  EEG  device K-FDA  certified

    2022

    2022.01  Grade 3 GMP certified

    2022.01 CES participated

    2023

    2023.01 CES participated

    2023.03 KIMES participated

    2023.11 MEDICA participated

    {"google":["Poppins","Lato"],"custom":["Noto Sans KR","Nanum Barun Gothic","SCDream"]}{"google":["Poppins","Lato","Oswald"],"custom":["Noto Sans KR","Nanum Barun Gothic","SCDream"]}

    CEO  Soonhyouk Lee｜COMPANY   Megnosis Co., Ltd.

    Company Registration Number   461-88-01594｜Address   #S102, 11-3 Techno 1-ro, Yuseong-gu, Daejeon, Korea 34015

    Tel   042-721-1102｜E-mail   contact@megnosis.com｜Admin

    COPYRIGHT (C) Megnosis. All Rights reserved

    CEO  Soonhyouk  Lee

    COMPANY   Megnosis Co., Ltd.

    Company Registration Number   461-88-01594

    Address   #S102, 11-3 Techno 1-ro, Yuseong-gu,

    Daejeon, Korea 34015

    Tel   042-721-1102 

    E-mail   contact@megnosis.com

    Admin

    {"google":[],"custom":["Noto Sans KR"]}